GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating how this dual effect impacts health. Anti-obesity drugs such as semaglutide (Ozempic, Wegovy), are showing potential beyond obesity treatment. Research increasingly suggests that these drugs may help manage alcohol use disorder and alcohol-related liver disease by reducing the desire to […]
Source link
Home Blog Taking Ozempic? Yale Researchers Say You’ll Handle Alcohol “Differently” and It Could Be Risky